Correlation between magnetic resonance imaging-based radiological response after 8 weeks of neoadjuvant chemoradiotherapy and postoperative histopathological response in rectal adenocarcinoma

Vijay K. Saini; Gaurav Singh; Sudip Regmi; Shakeel Masood; Anshuman Pandey

doi:10.18203/2349-3259.ijct20260045

Authors

Vijay K. Saini Department of Surgical Gastroenterology, Sarojini Naidu Medical College, Agra, Uttar Pradesh, India
Gaurav Singh Department of Surgical Oncology, Sarojini Naidu Medical College in Agra, Uttar Pradesh, India
Sudip Regmi Department of Surgical Gastroenterology, RMLIMS, Lucknow, Uttar Pradesh, India
Shakeel Masood Department of Surgical Gastroenterology, RMLIMS, Lucknow, Uttar Pradesh, India
Anshuman Pandey Department of Surgical Gastroenterology, RMLIMS, Lucknow, Uttar Pradesh, India

DOI:

https://doi.org/10.18203/2349-3259.ijct20260045

Keywords:

Rectal cancer, Neoadjuvant chemoradiotherapy, Magnetic resonance imaging, Tumor regression grade, Pathological complete response, Radiological-histopathological correlation

Abstract

Background: Neoadjuvant chemoradiotherapy (NACRT) is the standard of care for locally advanced rectal adenocarcinoma, facilitating tumor downstaging and improving surgical outcomes. Magnetic resonance imaging (MRI) is widely used to assess treatment response after NACRT; however, its ability to accurately predict histopathological tumor regression remains variable. Reliable radiological prediction is essential for individualized treatment planning and consideration of organ-preserving strategies.

Methods: This prospective observational study included 47 patients with mid or low rectal adenocarcinoma (≤12 cm from the anal verge) who received long-course NACRT followed by total mesorectal excision. Pelvic MRI performed 8 weeks post-NACRT assessed tumor response using the MRI tumor regression grade (mrTRG). Histopathological response was evaluated using the Rödel tumor regression grade (TRG) system. Correlation between mrTRG and pathological TRG was analyzed using Spearman’s correlation, and the diagnostic accuracy of MRI in predicting pathological complete response (pCR) was calculated.

Results: MRI demonstrated mrTRG 1–2 in 22 patients (46.8%), mrTRG 3 in 16 (34.0%), and mrTRG 4–5 in 9 (19.1%). Histopathology revealed pCR (TRG 0) in 11 patients (23.4%). MRI correctly identified 8 of 11 pCR cases. MRI prediction of pCR showed a sensitivity of 72.7%, specificity of 85.3%, positive predictive value of 61.5%, and negative predictive value of 90.3%. A significant correlation was observed between mrTRG and pathological TRG (Spearman’s r=0.64, p<0.001).

Conclusions: MRI-based assessment at 8 weeks post-NACRT demonstrates a significant correlation with histopathological response and provides reliable exclusion of complete response. Integration with clinical assessment is recommended for optimal treatment decision-making.

Metrics

Metrics Loading ...

References

Sauer R, Becker H, Hohenberger W, Rödel C, Wittekind C, Fietkau R, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004;351(17):1731-40. DOI: https://doi.org/10.1056/NEJMoa040694

Sebag-Montefiore D, Stephens RJ, Steele R, Monson J, Grieve R, Khanna S, et al. Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Lancet. 2009;373(9666):811-20. DOI: https://doi.org/10.1016/S0140-6736(09)60484-0

Maas M, Nelemans PJ, Valentini V, Das P, Rödel C, Kuo LJ, et al. Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data. J Clin Oncol. 2010;28(10):1781-8. DOI: https://doi.org/10.1016/S1470-2045(10)70172-8

Habr-Gama A, Perez RO, Nadalin W, Sabbaga J, Ribeiro U Jr, Silva e Sousa AH Jr, et al. Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results. Ann Surg. 2004;240(4):711-7. DOI: https://doi.org/10.1097/01.sla.0000141194.27992.32

Patel UB, Taylor F, Blomqvist L, George C, Evans H, Tekkis P, et al. Magnetic resonance imaging–detected tumor response for locally advanced rectal cancer predicts survival outcomes: MERCURY experience. J Clin Oncol. 2011;29(27):3753-60. DOI: https://doi.org/10.1200/JCO.2011.34.9068

Taylor FG, Quirke P, Heald RJ, Moran BJ, Blomqvist L, Swift IR, et al. Preoperative magnetic resonance imaging assessment of circumferential resection margin predicts disease-free survival and local recurrence: 5-year follow-up results of the MERCURY study. J Clin Oncol. 2014;32(1):34-43. DOI: https://doi.org/10.1200/JCO.2012.45.3258

van der Paardt MP, Zagers MB, Beets-Tan RG, Stoker J, Bipat S. Patients who undergo preoperative chemoradiotherapy for locally advanced rectal cancer restaged by using diagnostic MR imaging: a systematic review and meta-analysis. Radiology. 2013;269(1):101-12. DOI: https://doi.org/10.1148/radiol.13122833

Beets-Tan RG, Lambregts DM, Maas M, Bipat S, Barbaro B, Caseiro-Alves F, et al. Magnetic resonance imaging for clinical management of rectal cancer: updated recommendations from the 2016 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meeting. Lancet Oncol. 2018;19(2):e62-71.

Jhaveri KS, Hosseini-Nik H. MRI of rectal cancer: an overview and update on recent advances. Abdom Radiol (NY). 2021;46(10):4640-54.

Smith NJ, Barbachano Y, Norman AR, Swift RI, Abulafi AM, Brown G. Prognostic significance of magnetic resonance imaging–detected extramural vascular invasion in rectal cancer. Br J Surg. 2008;95(2):229-36. DOI: https://doi.org/10.1002/bjs.5917

Lambregts DM, Maas M, Riedl RG, Bakers FC, Lahaye MJ, Beets GL, et al. Value of diffusion-weighted MRI in predicting pathological complete response after chemoradiation for rectal cancer: a systematic review. Eur Radiol. 2011;21(6):1203-10. DOI: https://doi.org/10.1007/s00330-010-2052-8